Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Baxter files European marketing application for HemAssist

May 8, 1997

CSID enzyme replacement therapy submitted for approval

May 8, 1997

FDA decision on generic Premarin

May 8, 1997

Kissei licenses antidiabetic agent to Purdue

May 8, 1997

Genentech enters into agreement for embryonic stem cell renewal factor

May 8, 1997

Senetek seeks European approval of erectile dysfunction therapy

May 8, 1997

DEA recommends descheduling of Redux

May 7, 1997

Fosamax cleared as preventive medication in osteoporosis

May 7, 1997

Gene Logic and Johns Hopkins University enter into research collaboration

May 7, 1997

SmithKline Beecham's Androderm now available as a single patch system

May 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...